Skip to main content
SpringerLink
Log in

HSP90: The Unsung Villain of Sepsis?

  • Conference paper
Book cover Yearbook of Intensive Care and Emergency Medicine

Part of the book series: Yearbook of Intensive Care and Emergency Medicine ((YEARBOOK,volume 2006))

  • 658 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Banerji U, Judson I, Workman P (2003) The clinical applications of heat shock protein inhibitors in cancer — present and future. Curr Cancer Drug Targets 3:385–390

    Article  CAS  PubMed  Google Scholar 

  2. Csermely P, Schnaider T, Soti C, Prohaszka Z, Nardai G (1998) The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review. Pharmacol Ther 79:129–168

    Article  CAS  PubMed  Google Scholar 

  3. Matthews RC, Burnie JP (1995) Heat Shock Proteins in Fungal Infections. RG Landes Company Texas, USA, pp 80–150

    Google Scholar 

  4. Matthews RC, Burnie JP (2005) Human recombinant antibody to HSP90: A natural partner in combination therapy. Cur Mol Med 5:403–411

    Article  CAS  Google Scholar 

  5. Neckers L, Neckers K (2005) Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics — an update. Expert Opin Emerg Drugs 10:137–149

    Article  CAS  PubMed  Google Scholar 

  6. Saito K, Dai Y, Ohtsuka K (2005) Enhanced expression of heat shock proteins in gradually dying cells and their release from necrotically dead cells. Exp Cell Res 310:229–236

    Article  CAS  PubMed  Google Scholar 

  7. Basu S, Binder RJ, Ramalingam T, Srivastava PK (2001) CD91 is a common receptor for heat shock proteins gp96, HSP90, HSP70, and calreticulin. Immunity 14:303–313

    Article  CAS  PubMed  Google Scholar 

  8. Matzinger P (2002) The danger model: a renewed sense of self. Science 296:301–305

    Article  CAS  PubMed  Google Scholar 

  9. Matthews RC, Burnie JP, Tabaqchali S (1984) Immunoblot analysis of the serological response in systemic candidosis. Lancet ii:1415–1418

    Article  Google Scholar 

  10. Matthews RC, Burnie JP, Tabaqchali S (1987) Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans. J Clin Microbiol 25:230–237

    CAS  PubMed  Google Scholar 

  11. Conroy SE, Sasieni PD, Fentiman I, Latchman DS (1998) Autoantibodies to the 90 kDa heat shock protein and poor survival in breast cancer patients. Eur J Cancer 34:942–943

    CAS  PubMed  Google Scholar 

  12. Trieb K, Gerth R, Holzer G, Grohs JG, Berger P, Kotz R (2000) Antibodies to heat shock protein 90 in osteosarcoma patients correlate with response to neoadjuvant chemotherapy. Br J Cancer 82:85–87

    Article  CAS  PubMed  Google Scholar 

  13. Vidal CI, Mintz PJ, Lu K, et al (2004) An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patients. Oncogene 23:8859–8867

    Article  CAS  PubMed  Google Scholar 

  14. Minota S, Koyasu S, Yahara I, Winfield J (1998) Auto antibodies to the heat-shock protein HSP90 in systemic lupus erythematosus. J Clin Invest 81:106–109

    Article  Google Scholar 

  15. Jarjour WN, Jeffries BD, Davis JST, Welch WJ, Mimura T, Winfield JB (1991) Autoantibodies to human stress proteins. A survey of various rheumatic and other inflammatory diseases. Arthritis Rheum 34:1133–1138

    Article  CAS  PubMed  Google Scholar 

  16. Pashov A, Kenderov A, Kyurkchiev S, Kehayov I, Hristova S, Lacroix-Desmazes S (2002) Autoantibodies to heat shock protein 90 in the human natural antibody repertoire. Int Immunol 14:453–461

    Article  CAS  PubMed  Google Scholar 

  17. Bonnefoy S, Gysin J, Blisnick T, et al (1994) Immunogenicity and antigenicity of a Plasmodium falciparum protein fraction (90–110 kDa) able to protect squirrel monkeys against asexual blood stages. Vaccine 12:32–40

    Article  CAS  PubMed  Google Scholar 

  18. Kumar R, Musiyenko A, Barik S (2005) Plasmodium falciparum calcineurin and its association with heat shock protein 90; mechanisms for the antimalarial activity of cyclosporine A and geldanamycin Mol Biochem Parasitol 141:29–37

    Article  CAS  PubMed  Google Scholar 

  19. Nooney L, Matthews RC, Burnie JP (2005) Evaluation of Mycograb®, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies. Diagn Microbiol Infect Dis 51:19–29

    Article  CAS  PubMed  Google Scholar 

  20. Denikus N, Orfaniotou F, Wulf G, Lehmann PF, Monod M, Reichard U (2005) Fungal antigens expressed during invasive aspergillosis. Infect Immun 73:4704–4713

    Article  CAS  PubMed  Google Scholar 

  21. Ferreira RP, Yu B, Niki Y, Armstrong D (1990) Detection of Candida antigenuria in disseminated candidiasis by immunoblotting. J Clin Microbiol 28:1075–1078

    CAS  PubMed  Google Scholar 

  22. Matthews RC, Burnie JP (1988) Diagnosis of systemic candidiasis by an enzyme-linked dot immunobinding assay for a circulating immunodominant 47-kilodalton antigen. J Clin Microbiol 26:459–463

    CAS  PubMed  Google Scholar 

  23. Hodgetts S, Matthews RC, Morrissey G, Mitsutake K, Piper P, Burnie JP (1996) Over-expression of Saccharomyces cerevisiae HSP90 enhances the virulence of this yeast in mice. FEMS Immunol Med Microbiol 16:229–234

    Article  CAS  PubMed  Google Scholar 

  24. Louvion JF, Abbas-Terki T, Picard D (1998) Hsp90 is required for pheromone signaling in yeast. Mol Biol Cell 9:3071–3083

    CAS  PubMed  Google Scholar 

  25. Panwar SL, Legrand M, Dignard D, Whiteway M, Magee PT (2003) MFalphal, the gene encoding the alpha mating pheromone of Candida albicans. Eukaryot Cell 2:1350–1360

    Article  CAS  PubMed  Google Scholar 

  26. Burnie JP, Carter TL, Hodgetts SJ, Matthews RC (2006) Fungal heat-shock proteins in human disease. FEMS Microbiol Rev (in press)

    Google Scholar 

  27. Sreedhar AS, Mihaly K, Pato B, Schnaider T, Stetak A, Kis-Petik K (2003) Hsp90 inhibition accelerates cell lysis. Anti-Hsp90 ribozyme reveals a complex mechanism of Hsp90 inhibitors involving both superoxide — and Hsp90-dependent events. J Biol Chem 278:35231–35240

    Article  CAS  PubMed  Google Scholar 

  28. Matthews RC, Rigg G, Hodgetts S, et al (2003) Preclinical assessment of the efficacy of Mycograb®, a human recombinant antibody against fungal HSP90. Antimicrob Agents Chemother 47:2208–2216

    Article  CAS  PubMed  Google Scholar 

  29. Yang Q, Wang L, Lu DN, et al (2005) Prophylactic vaccination with phage-displayed epitope of C. albicans elicits protective immune responses against systemic candidiasis in C57BL/6 mice. Vaccine 23:4088–4096

    Article  CAS  PubMed  Google Scholar 

  30. Raska M, Belakova J, Wudattu NK, et al (2005) Comparison of protective effect of protein and DNA vaccines HSP90 in murine model of systemic candidiasis. Folia Microbiol (Praha) 50:77–82

    Article  CAS  Google Scholar 

  31. Lopatin DE, Jaramillo E, Edwards CA, Van Poperin N, Combs A, Shelburne CE (1999) Cellular localization of a Hsp90 homologue in Porphyromonas gingivalis. FEMS Microbiol Lett 181:9–16

    Article  CAS  PubMed  Google Scholar 

  32. Miyaoka K, Iwase M, Suzuki R, et al (2005) Clinical evaluation of circulating interleukin-6 and interleukin-10 levels after surgery-induced inflammation. J Surg Res 125:144–150

    Article  CAS  PubMed  Google Scholar 

  33. Mokart D, Merlin M, Sannini A, et al (2005) Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth 94:767–773

    Article  CAS  PubMed  Google Scholar 

  34. Van Enckevort FH, Netea MG, Hermus AR, et al (1999) Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice. Med Mycol 37:419–426

    Article  PubMed  Google Scholar 

  35. Scott MJ, Godshall CJ, Cheadle WG (2002) Jaks, STATs, Cytokines, and Sepsis. Clin Diagn Lab Immunol 9:1153–1159

    CAS  PubMed  Google Scholar 

  36. Wax S, Piecyk M, Maritim B, Anderson P (2003) Geldanamycin inhibits the production of inflammatory cytokines in activated macrophages by reducing the stability and translation of cytokine transcripts. Arthritis Rheum 48:541–550

    Article  CAS  PubMed  Google Scholar 

  37. Shah M, Patel K, Fried VA, Sehgal PB (2002) Interactions of STAT3 with caveolin-1 and heat shock protein 90 in plasma membrane raft and cytosolic complexes. Preservation of cytokine signaling during fever. J Biol Chem 277:45662–45669

    Article  CAS  PubMed  Google Scholar 

  38. Garcia-Cardena G, Fan R, Shah V, et al (1998) Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 392:821–824

    Article  CAS  PubMed  Google Scholar 

  39. Shastry S (2002) Geldanamycin attenuates NO-mediated dilation in human skin. Am J Physiol Heart Circ Physiol 282:H232–236

    CAS  PubMed  Google Scholar 

  40. Fontana J, Fulton D, Chen Y, Fairchild TA, McCabe TJ, Fujita, N (2002) Domain mapping studies reveal that the M domain of HSP90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ Res 90:866–873

    Article  CAS  PubMed  Google Scholar 

  41. Papapetropoulos A, Fulton D, Lin MI, et al (2004) Vanadate is a potent activator of endothelial nitric-oxide synthase: evidence for the role of the serine/threonine kinase Akt and the 90-kDa heat shock protein. Mol Pharmacol 65:407–415

    Article  CAS  PubMed  Google Scholar 

  42. Bucci M, Roviezzo F, Posadas I, et al (2005) Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. Proc Natl Acad Sci USA 102:904–908

    Article  CAS  PubMed  Google Scholar 

  43. Joseph K, Tholanikunnel BG, Kaplan AP (2002) Activation of the bradykinin-forming cascade on endothelial cells: a role for heat shock protein 90. Int Immunopharmacol 2:1851–1859

    Article  CAS  PubMed  Google Scholar 

  44. Pixley RA, DeLa Cadena RA, et al (1992) Activation of the contact system in lethal hypotensive bacteremia in a baboon model. Am J Pathol 140:897–906

    CAS  PubMed  Google Scholar 

  45. Heitman J (2005) A fungal Achilleś heel. Science 309:2175–2176

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Microbiology, Manchester Royal Infirmary, Oxford Road, Manchester, M13 9WL, UK

    J. P. Burnie & R. C. Matthews

Authors
  1. J. P. Burnie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. C. Matthews
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Intensive Care, Erasme Hospital, Free University of Brussels, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean-Louis Vincent (Head) (Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Burnie, J.P., Matthews, R.C. (2006). HSP90: The Unsung Villain of Sepsis?. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine. Yearbook of Intensive Care and Emergency Medicine, vol 2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-33396-7_4

Download citation

  • DOI: https://doi.org/10.1007/3-540-33396-7_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-30155-4

  • Online ISBN: 978-3-540-33396-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation